PT - JOURNAL ARTICLE AU - Law, Jing Hui AU - Sultan, Najia AU - Finer, Sarah AU - Fudge, Nina TI - Advancing the communication of genetic risk for cardiometabolic diseases: A critical interpretive synthesis AID - 10.1101/2023.05.12.23289038 DP - 2023 Jan 01 TA - medRxiv PG - 2023.05.12.23289038 4099 - http://medrxiv.org/content/early/2023/05/15/2023.05.12.23289038.short 4100 - http://medrxiv.org/content/early/2023/05/15/2023.05.12.23289038.full AB - Background Genetics play an important role in risk for cardiometabolic diseases—including type 2 diabetes, cardiovascular disease and obesity. Existing research has explored the clinical utility of genetic risk tools such as polygenic risk scores—and whether interventions communicating genetic risk information using these tools can impact on individuals’ cognitive appraisals of disease risk and/or preventative health behaviours. Previous systematic reviews exploring the evidence base suggest mixed results. To expand current understanding and address knowledge gaps, we undertook a reflexive method of evidence synthesis to the literature—questioning the theoretical basis behind current interventions that communicate genetic risk information and exploring how the effects of genetic risk tools can be fully harnessed for cardiometabolic diseases.Methods We obtained 188 records from a combination of database, website and grey literature searches—supplemented with reference chaining and expert subject knowledge within the review team. Using pre-defined critical interpretive synthesis methods, quantitative and qualitative evidence was synthesised and critiqued alongside theoretical understanding from surrounding fields of behavioural and social sciences.Findings Existing interventions communicating genetic risk information focus predominantly on the “self”, targeting individual-level cognitive appraisals, such as perceived risk and perceived behavioural control. This approach risks neglecting the role of contextual factors and upstream determinants that can reinforce individuals’ interpretations of risk. It also assumes target populations to embody an “ascetic subject of compliance”—the idea of a patient who strives to comply diligently with professional medical advice, logically and rationally adopting any recommended lifestyle changes. We developed a synthesising argument—beyond the “ascetic subject of compliance”—grounded in three major limitations of this perspective: (1) Difficulty applying existing theories/models to diverse populations; (2) The role of familial variables and (3) The need for a life course perspective.Conclusions Interventions communicating genetic risk information should account for wider influences that can affect individuals’ responses to risk at different levels—including through interactions with their family systems, socio-cultural environments and wider health provision.Protocol registration PROSPERO CRD42021289269Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was made possible by funding from the Wellcome Trust for JHL through the doctoral training programme Health Data in Practice: Human-centred Science (Reference: 218584/Z/19/Z).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript.CENTRALthe Cochrane Central Register of Controlled TrialsCISCritical interpretive synthesisCOM-Bthe Capability, Opportunity, Motivation, Behaviour modelCSM-SRthe Common Sense Model of Self RegulationCVDCardiovascular diseaseGWASsGenome-wide association studiesHBMthe Health Belief ModelPRSspolygenic risk scoresT2DType 2 diabetesTPBthe Theory of Planned Behaviour